Device Medical Device

(6371) Laser Cvx300

Payments companies reported to CMS as associated with (6371) Laser Cvx300. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$3,149associated payments (2023-2025)

37clinicians with associated payments

2companies reporting

By year

2023 $3,109

2024 $39.60

Payments reported as associated with (6371) Laser Cvx300, per program year, as reported to CMS.

Who makes it

Philips Electronics North America Corporation $3,099 associated with (6371) Laser Cvx300 (2023-2025)
Philips North America LLC $49.40 associated with (6371) Laser Cvx300 (2023-2025)

Specialties most often involved

Cardiovascular Disease $1,171

Interventional Cardiology $966

Vascular Surgery $368

Vascular & Interventional Radiology $153

Surgery $116

Internal Medicine $109

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with (6371) Laser Cvx300

These are the largest totals companies reported as associated with (6371) Laser Cvx300. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Garrett Wong	Sacramento, CA	Cardiovascular Disease	$274.88
Rishi Panchal	Royal Palm Beach, FL	Cardiovascular Disease	$243.80
Jeffrey Rubinstein	Lakewood, CO	Interventional Cardiology	$124.99
Pradeep Nair	Houma, LA	Interventional Cardiology	$123.80
Craig Walker	Houma, LA	Interventional Cardiology	$123.80
Micah Watts	Galloway, NJ	Vascular & Interventional Radiology	$114.52
Lily Chen	Sacramento, CA	Cardiovascular Disease	$109.41
Tai Pham	Sacramento, CA	Internal Medicine	$109.40
Sanah Christopher	Richmond, VA		$109.40
Roshni Khatiwala	Sacramento, CA	Cardiovascular Disease	$109.40

Prescribed (6371) Laser Cvx300?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.